Editorial: early post-induction anti-TNF drug monitoring can predict long-term therapeutic outcomes in inflammatory bowel disease

被引：0
|
作者：
Papamichael, K. [1 ]
Cheifetz, A. S. [1 ]
机构：
[1] Harvard Med Sch, Div Gastroenterol, Beth Israel Deaconess Med Ctr, Ctr Inflammatory Bowel Dis, Boston, MA 02115 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2018年 / 47卷 / 03期
关键词：
ULCERATIVE-COLITIS; CROHNS-DISEASE; INFLIXIMAB;
D O I：
10.1111/apt.14461
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：436 / 437
页数：2
相关论文
共 50 条
  • [21] ATTITUDE AND BARRIERS TOWARDS THE IMPLEMENTATION OF THERAPEUTIC DRUG MONITORING OF ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASE CLINICAL PRACTICE
    Grossberg, Laurie B.
    Papamichail, Konstantinos
    Feuerstein, Joseph D.
    Cheifetz, Adam S.
    GASTROENTEROLOGY, 2017, 152 (05) : S390 - S391
  • [22] Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science?
    Samaan, Mark A.
    Arkir, Zehra
    Ahmad, Tariq
    Irving, Peter M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (12) : 1271 - 1279
  • [23] A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease
    Grossberg, Laurie B.
    Papamichael, Konstantinos
    Feuerstein, Joseph D.
    Siegel, Corey A.
    Ullman, Thomas A.
    Cheifetz, Adam S.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (01) : 191 - 197
  • [24] Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease
    Ha, Christina
    Mathur, Jagrati
    Kornbluth, Asher
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (04) : 497 - 505
  • [25] LONG-TERM OUTCOMES OF PROACTIVE VERSUS REACTIVE THERAPEUTIC DRUG MONITORING FOR OPTIMIZING INFLIXIMAB THERAPY IN INFLAMMATORY BOWEL DISEASE
    Papamichail, Konstantinos
    Chachu, Karen A.
    Vajravelu, Ravy K.
    Vaughn, Byron P.
    Ni, Josephine
    Cheifetz, Adam S.
    Osterman, Mark T.
    GASTROENTEROLOGY, 2017, 152 (05) : S381 - S382
  • [26] Long-term evolution after anti-TNF discontinuation in patients with inflammatory bowel disease (IBD): A multicentre study
    Casanova, M. J.
    Chaparro, M.
    Nantes, O.
    Benitez, J. M.
    Rojas-Feria, M.
    Castro-Poceiro, J.
    Huguet, J. M.
    Martin-Cardona, A.
    Aicart, M.
    Tosca, J.
    Martin-Rodriguez, M. D. M.
    Gonzalez-Munoza, C.
    Manosa, M.
    Leo-Carnerero, E.
    Lamuela, L.
    Perez-Martinez, I.
    Bujanda, L.
    Hinojosa, J.
    Pajares, R.
    Arguelles-Arias, F.
    Perez-Calle, J. L.
    Rodriguez-Gonzalez, G. E.
    Guardiola, J.
    Barreiro-de Acosta, M.
    Bermejo, F.
    Barrio, J.
    Beltran, B.
    Gomollon, F.
    Lorente, R.
    Gutierrez, A.
    Dominguez-Cajal, M.
    Duenas, C.
    Ponferrada-Diaz, A.
    Van Domselaar, M.
    Ramirez-De la Piscina, P.
    Ramos, L.
    Almela, P.
    Navarro-Llavat, M.
    Botella, B.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S359 - S360
  • [27] Can CD74 Predict Treatment Response to Anti-TNF Agents in Inflammatory Bowel Disease?
    Farr, Laura
    Bucala, Richard
    Moonah, Shannon
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S480 - S480
  • [28] Early proactive therapeutic drug monitoring program for management of infliximab in inflammatory bowel disease: long-term durability of treatments
    Sanchez-Hernandez, J. G.
    Rebollo, N.
    Munoz, F.
    Saez-Fernandez, E. M.
    Rodriguez-Rodriguez, G.
    Tapia-Artiles, C.
    Fernandez-Caballero, R.
    Calvo, M. V.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 232 - 233
  • [29] Effect of an Anti-TNF Therapeutic Drug Monitoring Quality Improvement Program on Inflammatory Bowel Disease Patient Outcomes at a Large Academic Pediatric Gastroenterology Practice
    Mulgund, Aditi A.
    Bauman, Laura
    Chona, Deepika L.
    Sharma, Puneet
    Su, Weizhe
    Fei, Lin
    Denson, Lee A.
    Minar, Phillip
    Dykes, Dana M.
    Rosen, Michael J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S402 - S403
  • [30] Clinical value of routine therapeutic anti-TNF drug monitoring (TDM) in Inflammatory Bowel Disease (IBD) patients in clinical practice
    Guirgis, M.
    Bianchetti, D.
    Dorta, G.
    Michetti, P.
    Maillard, M.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S235 - S236
12345